You are here: All Products  > Hengrui Medicine Licenses Cancer Drug to Incyte in $795 Million Deal

Hengrui Medicine Licenses Cancer Drug to Incyte in $795 Million Deal

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products